The Effect of Finasteride in Men with Benign Prostatic Hyperplasia

19921,131 citationsJournal Articlebronze Open Access

Authors

Glenn J. Gormley · Merck & Co., Inc., Rahway, NJ, USA (United States)

Elizabeth Stoner

Reginald C. Bruskewitz

Julianne Imperato‐McGinley

Abstract

The treatment of benign prostatic hyperplasia with 5 mg of finasteride per day results in a significant decrease in symptoms of obstruction, an increase in urinary flow, and a decrease in prostatic volume, but at a slightly increased risk of sexual dysfunction.

Topics & Keywords

Urinary Bladder and Prostate Research Sexual function and dysfunction studies Pelvic floor disorders treatments

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: New England Journal of Medicine

Volume 327, Issue 17, pp. 1185-1191

DOI: 10.1056/nejm199210223271701

Field-Weighted Citation Impact: 77.07